Core Viewpoint - Tianyuan Medical (00557) announced that Tianyuan Manganese informed the company about an internal equity restructuring scheduled for December 17, 2025, involving a share transfer agreement between Ningxia Tianyuan Group and Ningxia Tianyuan Co., which will result in the transfer of 100% equity of Tianyuan Manganese to Ningxia Tianyuan Co. [1] Group 1 - The restructuring was completed on the same day it was announced, December 17, 2025 [1] - Prior to the restructuring, Tianyuan Manganese directly held approximately 66.69% of the total issued shares of the company [1] - Tianyuan Manganese was wholly owned by Ningxia Tianyuan Group, which is directly held by Mr. Jia, who owns approximately 99.99% [1] Group 2 - After the restructuring, Tianyuan Manganese is directly held 100% by Ningxia Tianyuan Co., while Ningxia Tianyuan Co. remains wholly owned by Ningxia Tianyuan Group, which is also directly held by Mr. Jia [1] - Tianyuan Manganese continues to hold approximately 66.69% of the total issued shares of the company [1] - The board believes that the restructuring will not have any significant impact on the management and operations of the company [1]
天元医疗(00557)：控股股东股权架构变动 天元锰业仍为公司的直接控股股东